Antabio SAS announced the hiring of biotech executives to its management team.    Starting January 1st 2018 and on a part-time basis, Gordon Waldron will lead Finance, Carole Sable will oversee Clinical Strategy, Helmuth van Es will direct Business Development and David Lathbury will manage CMC activities.   These executives have built strong track records directing and growing innovative biotech companies, forging alliances, maximizing shareholder value and taking products throu...